Sander van Deventer
CIK 1543084 · EVP, Research & Product Dev. · last filed 2020-10-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.97M
Companies
3
Total Filings
25
Lifetime Open-Market Net
$693
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 3
25 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-01-31 | QURE | Sell (S) | −5,985 | -$110.9K | EDGAR |
| 2018-01-30 | QURE | Grant (A) | +7,795 | $0 | EDGAR |
| 2017-09-22 | QURE | Grant (A) | — | $0 | EDGAR |
| 2017-01-31 | QURE | Grant (A) | — | $0 | EDGAR |
| 2017-01-20 | ARGOS THERAPEUTICS INC (ARGS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-10-03 | ARGOS THERAPEUTICS INC (ARGS) Delisted | Grant (A) | +2,263 | $0 | EDGAR |
| 2016-08-04 | ARGOS THERAPEUTICS INC (ARGS) Delisted | Buy (P) | +1,545,454 | $0 | EDGAR |
| 2016-07-05 | ARGOS THERAPEUTICS INC (ARGS) Delisted | Grant (A) | +1,427 | $0 | EDGAR |
| 2016-07-01 | ARGOS THERAPEUTICS INC (ARGS) Delisted | Buy (P) | +1,322,618 | $0 | EDGAR |
| 2016-06-14 | ARGOS THERAPEUTICS INC (ARGS) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.